Aportes al estudio de la drepanocitosis. Análisis clínico y hematológico en los primeros 5 años de la vida

Revista Cubana de Hematologia, Inmunologia y Hemoterapia

Volumn 15, Issue 2, 1999, Pages 96-104

  Peralta, Tania García ^a   Carrera, Ileana Nordet ^a   García, Sergio Machín ^a   Otero, Alejandro González ^a   Fernández, Adriana Muñiz ^a   Antuña, Gisela Martínez ^a   Mateo, Maura Wade ^a,b   Svarch, Eva ^a  

^a INSTITUTO DE HEMATOLOGÍA E INMUNOLOGÍA   (Cuba)

^b INSTITUTO NACIONAL DE HIGIENE   (Cuba)

Author keywords

Anemia, sickle cell blood; Beta thalassemia blood; Hemoglobin SC blood

Indexed keywords

EID: 0347829538     PISSN: 08640289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Colombo B, Svarch E, Martínez G. Genética y clínica de las hemoglobinas humanas. La Habana: Editorial Pueblo y Educación, 1994.
2. Betke K, Martín H, Schlicht I. Estimation of small percentages of foetal hemoglobin. Nature 1959;184:1877.
3. Nagel RL, Rao SK, Dunda-Belkhodja O, Connolly MM, Fabry ME, George A, et al. The hematological characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G and HbF level. Blood 1987;69:1026-30.
4. Higgs D, Aldridge B, Lamb J, Hayes RJ, Grandison I, Lowrie I, et al. The interaction of alpha thalassemia and homozygous sickle cell disease. N Engl J Med 1982;306:1441-6.
5. Still R, Torrie J. Principles and procedures of statistics. New York:McGraw Hill, 1960:406.
6. Powars DR. Natural history of sickle cell disease. The first ten years. Semin Hematol 1975;12:267-85.
7. Murtaza LN, Strovd CE, Davis LR, Cooper DJ. Admissions to hospital of children with sickle cell anaemia: a study in South London. Br Med J 1981;282:1048-51.
8. Pegelow CH, Armstrong FD, Light S, Toledano SR, Davis J. Experience with the use of prophylactic in children with sickle cell anemia. J Pediatr 1991;118:736-8.
9. Leggiadro RJ. The clinical impact of resistance in the management of pneumococcal disease. Infect Dis Clin North Am 1997;11:867-74.
10. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Sott RB, Gillete Vera JC, et al. The acute chest syndrome in sickle cell disease. Incidence and risk factors. Blood 1994;84:643-9.
11. Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease. A retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol 1986;8:105-10.
12. Vishinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol 1991;28:220-6.
13. Piatt OS, Brombilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
14. Hvo MH, Friedlaender GE, Marsh JS. Orthopoedic manifestations of sickle cell disease. Yale J Biol Med 1990;63:195-207.
15. Emond A, Collis R, Darvill D, Higg DR, Maude Gtl, Serjeant GR. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 1985;107:201-6.
16. De Montalembert M, Guilloud-Bataille M, Feinglod J, Girot R. Epidemiological and clinical study of sickle cell disease in France, French Guiana and Algeria. Eur J Haematol 1993;51:136-40.
17. Luban N. Variability in rates of alloinmunization in different groups in children with sickle cell disease: effect of ethnic back ground. Am J Pediatr Hematol Oncol 1989;11:314-9.
18. William S, Maude GH, Serjeant GR. Clinical presentation of sickle cell hemoglobin C disease. J Pediatr 1986;109:586-9.
19. + thalassemia: is prophylactics penicillin necessary? J Pediatr 1995;127:348-51.
20. Pearson HA, Gallagher D, Chilcote R, Sulliran E, Willimas J, Espeland M, et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 1985;76:392-7.
21. Serjeant GR, Grandison Y, Lowrie Y, Vaidya S, Mason KP, et al. The development of haemotological changes in homozygous sickle cell disease: a cohort study from birth to 6 years. Br J Haematol 1981;48:533-43.
22. Chang YC, Maier-Redelsperger M, Smith KD, Contul DR, De Montalembert M. The relative importance of X-linked FCP locus and β-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for S haplotypes. Br J Haematol 1997;96:806-14.
23. Hayes RJ, Beckford M, Grandison Y, Mason K, Serjeant GR. The haematology of the steady state homozygous sickle cell disease: frequency distributions, variations with age and sex, longitudinal observation. Br J Haematol 1985;59:369-82.
24. West MS, Wethers D, Smith J, Steinberg M. The Cooperative Study of Sickle Cell Disease. Laboratory profile of sickle cell disease: a cross-sectional analysis. J Clin Epidemiol 1992;45:893-909.
25. Serjeant GR. Sickle cell disease. Oxford: University, 1985;289-95.
26. Muñíz A, Corral L, Aláez C, Svarch E, Espinosa E, Carbonell N, et al. Sickle cell anemia and β-gene cluster haplotype in Cuba. Am J Hematol 1995;49:163-4.
27. 7. Nagel R, Fabry M, Pagrier J. Hematological and genetic markers in sickle cell disease. Semin Hematol 1991;28:180-201.
28. Nagel RL. Severity, pathobiology, epistatic effect and genetic markers in sickle cell anemia. Semin Hematol 1991;28:180-201.
29. Charache S, Teerin ML, Moore RD, Dover GJ, Barton FB, Eckerts SV, et al. Study of hydroxyurea in sickle cell anemia. N Eng J Med 1995;332:1317-32.
30. Rogers ZR. Hydroxyurea therapy for diverse pediatric population with sickle cell disease. Semin Hematol 1997;34:42-7.
31. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. Bone marrow tranplantion for sickle cell disease. N Engl J Med 1996;335:369-76.